Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule-associated proteins 1A/1B light chain 3B (LC3B) is a central protein in the macroautophagy pathway, essential for the formation, maturation, and cargo selection of autophagosomes (UniProt P60709). It undergoes a C-terminal cleavage by ATG4 to form the cytosolic LC3-I, which is subsequently conjugated to phosphatidylethanolamine to form LC3-II, the membrane-bound form used as a definitive hallmark of autophagic activity (PubMed: 23280503). LC3B acts as an adapter protein, interacting with LIR-containing cargo receptors like p62 to facilitate the selective degradation of cellular components such as damaged organelles or protein aggregates (PubMed: 28445460). In oncology, LC3-mediated autophagy can promote tumor survival under metabolic stress, making it a target for inhibitors like hydroxychloroquine which block the degradation of LC3-II (PubMed: 30229034). Conversely, enhancing LC3-dependent clearance is a therapeutic strategy for neurodegenerative diseases characterized by protein aggregation, such as Alzheimer's and Parkinson's (PubMed: 31160674). Current drug development also explores LC3-targeting chimeras (AUTACs) that leverage the LC3 machinery to direct specific pathogenic proteins for autophagic degradation (PubMed: 31806907).
Modulation of autophagic flux through the inhibition of autophagosome-lysosome fusion or the induction of autophagosome formation and cargo recruitment.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule-associated proteins 1A/1B light chain 3B (LC3B).